Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Outcome Trial Evaluating the Efficacy and Safety of Norditropin in Adult Patients on Chronic Haemodialysis
2006-004702-56Phase 3Terminated
- Sponsor
- Novo Nordisk
- Start
- Jun 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of somatropin in end-stage kidney disease (ESKD), sponsored by Novo Nordisk. Primary endpoint: Mortality. Started Jun 2007; status: terminated.
02
Drugs
somatropin
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on 2006-004702-56.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004702-56.